The potential role of echocardiographic strain imaging for evaluating cardiotoxicity due to cancer therapy

Heart Lung and Circulation

Volumn 20, Issue 1, 2011, Pages 3-9

  Stoodley, Paul W ^a   Richards, David A B ^b   Meikle, Steve R ^a,c   Clarke, Jillian ^a   Hui, Rina ^d   Thomas, Liza ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

Anthracyclines; Cardiotoxicity; Echocardiography; Left ventricular ejection fraction (LVEF); Strain; Strain rate; Trastuzumab

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; TRASTUZUMAB;

BREAST CANCER; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CHEMOTHERAPY RELATED CARDIAC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMAGING SYSTEM; LOW DRUG DOSE; MULTIPLE CYCLE TREATMENT; MYOCARDIAL STRAIN IMAGING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANTICARCINOGENIC AGENTS; ASYMPTOMATIC DISEASES; CARDIOTOXINS; CLINICAL TRIALS AS TOPIC; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; HEART DISEASES; IMAGE ENHANCEMENT; MONITORING, PHYSIOLOGIC; NEOPLASMS;

EID: 78650827039     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2010.09.007     Document Type: Review

References (43)

1. Cancer Statistics 2009 Presentation. Available from:; 2009. http://www.cancer.org/docroot/PRO/content/PRO_1_1Cancer_Statistics_2009_presentation.asp.
2. Singal P.K., Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998, 339(13):900-905.
3. Bird B.R., Swain S.M. Cardiac toxicity in breast cancer survivors: review of potential cardiac problems. Clin Cancer Res 2008, 14(1):14-24.
4. Jurcut R., Wildiers H., Ganame J., D'Hooge J., De Backer J., Denys H., et al. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr 2008, 21(12):1283-1289.
5. Arcamone F., Franceschi G., Penco S., Selva A. Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic. Tetrahedron Lett 1969, 13:1007-1010.
6. Lefrak E.A., Pitha J., Rosenheim S., Gottlieb J.A. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973, 32(2):302-314.
7. Shan K., Lincoff A.M., Young J.B. Anthracycline-induced cardiotoxicity. Ann Intern Med 1996, 125(1):47-58.
8. Singal P.K., Li T., Kumar D., Danelisen I., Iliskovic N. Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem 2000, 207(1-2):77-86.
9. Swain S.M., Whaley F.S., Ewer M.S. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 2003, 97(11):2869-2879.
10. Anthracyclines and mitoxantrone-cumulative dose cardiac toxicity. Available from:; 2009. https://www.treatment.cancerinsttiute.org.au/.
11. Grenier M.A., Lipshultz S.E. Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 1998, 25(4 Suppl. 10):72-85.
12. Dranitsaris G., Rayson D., Vincent M., Chang J., Gelmon K., Sandor D., et al. The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines. Breast Cancer Res Treat 2008, 107(3):443-450.
13. Gianni L., Herman E.H., Lipshultz S.E., Minotti G., Sarvazyan N., Sawyer D.B. Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol 2008, 26(22):3777-3784.
14. Hayes D.F., Picard M.H. Heart of darkness: the downside of trastuzumab. J Clin Oncol 2006, 24(25):4056-4058.
15. Piccart-Gebhart M.J., Procter M., Leyland-Jones B., Goldhirsch A., Untch M., Smith I., et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005, 353(16):1659-1672.
16. Rayson D., Richel D., Chia S., Jackisch C., van der Vegt S., Suter T. Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies. Ann Oncol 2008, 19(9):1530-1539.
17. Hare J.L., Brown J.K., Leano R., Jenkins C., Woodward N., Marwick T.H. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J 2009, 158(2):294-301.
18. Ewer M.S., Lippman S.M. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol 2005, 23(13):2900-2902.
19. Telli M.L., Hunt S.A., Carlson R.W., Guardino A.E. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol 2007, 25(23):3525-3533.
20. Wang T.J., Evans J.C., Benjamin E.J., Levy D., LeRoy E.C., Vasan R.S. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003, 108(8):977-982.
21. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18(12):1440-1463.
22. McGowan J.H., Cleland J.G. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J 2003, 146(3):388-397.
23. Malm S., Frigstad S., Sagberg E., Larsson H., Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 2004, 44(5):1030-1035.
24. Otterstad J.E. Measuring left ventricular volume and ejection fraction with the biplane Simpson's method. Heart 2002, 88(6):559-560.
25. Marwick T.H. Measurement of strain and strain rate by echocardiography: ready for prime time?. J Am Coll Cardiol 2006, 47(7):1313-1327.
26. Otterstad J.E., Froeland G., St John Sutton M., Holme I. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 1997, 18(3):507-513.
27. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002, 105(12):1503-1508.
28. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009, 53(15):e1-e90.
29. Gottdiener J.S., McClelland R.L., Marshall R., Shemanski L., Furberg C.D., Kitzman D.W., et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function The Cardiovascular Health Study. Ann Intern Med 2002, 137(8):631-639.
30. Stoddard M.F., Seeger J., Liddell N.E., Hadley T.J., Sullivan D.M., Kupersmith J. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol 1992, 20(1):62-69.
31. Yu C.M., Sanderson J.E., Marwick T.H., Oh J.K. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 2007, 49(19):1903-1914.
32. Jurcut R., Wildiers H., Ganame J., D'Hooge J., Paridaens R., Voigt J.U. Detection and monitoring of cardiotoxicity-what does modern cardiology offer?. Support Care Cancer 2008, 16(5):437-445.
33. Marwick T.H., Leano R.L., Brown J., Sun J.-P., Hoffmann R., Lysyansky P., et al. Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range. J Am Coll Cardiol Img 2009, 2:80-84.
34. Sun J.P., Popovic Z.B., Greenberg N.L., Xu X.F., Asher C.R., Stewart W.J., et al. Noninvasive quantification of regional myocardial function using Doppler-derived velocity displacement, strain rate, and strain in healthy volunteers: effects of aging. J Am Soc Echocardiogr 2004, 17(2):132-138.
35. Ganame J., Claus P., Uyttebroeck A., Renard M., D'Hooge J., Bijnens B., et al. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients. J Am Soc Echocardiogr 2007, 20(12):1351-1358.
36. Dokainish H., Sengupta R., Pillai M., Bobek J., Lakkis N. Usefulness of new diastolic strain and strain rate indexes for the estimation of left ventricular filling pressure. Am J Cardiol 2008, 101(10):1504-1509.
37. Serri K., Reant P., Lafitte M., Berhouet M., Le Bouffos V., Roudaut R., et al. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006, 47(6):1175-1181.
38. Eidem B.W. Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough. J Am Soc Echocardiogr 2008, 21(12):1290-1292.
39. Leung D.Y., Ng A.C. Emerging clinical role of strain imaging in echocardiography. Heart Lung Circ 2010, 19(3):161-174.
40. Argyle R.A., Ray S.G. Stress and strain: double trouble or useful tool?. Eur J Echocardiogr 2009, 10(6):716-722.
41. Tassan-Mangina S., Codorean D., Metivier M., Costa B., Himberlin C., Jouannaud C., et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr 2006, 7(2):141-146.
42. Neilan T.G., Jassal D.S., Perez-Sanz T.M., Raher M.J., Pradhan A.D., Buys E.S., et al. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J 2006, 27(15):1868-1875.
43. Piegari E., Di Salvo G., Castaldi B., Vitelli M.R., Rodolico G., Golino P., et al. Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model. Ultrasound Med Biol 2008, 34(3):370-378.